S. 4535 · 117th Congress · Senate

FDASRA Act of 2022

Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
Jul 14, 22
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Food and Drug Administration Simple Reauthorization Act of 2022 or the FDASRA Act of 2022

This bill reauthorizes the authority of the Food and Drug Administration to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such fees, including the base fee amounts.

Action Timeline

2
  1. JUL 14, 2022•IntroReferral

    Introduced in Senate

  2. JUL 14, 2022•IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees

1

Health, Education, Labor, and Pensions Committee

sshr00

Referred: Jul 14, 2022

Active